SIE 0.00% 6.8¢ scigen limited

research required !!!, page-2

  1. 696 Posts.
    lightbulb Created with Sketch. 20
    What a lot of ppl forget about a company like scigen is the low level of risk it does have compared to other biotech companies that are actually trying to bring a product to the commercialistion stage. Scigen has in place several agreements in place that should see revenues begin to grow very rapidly in the coming years and such will get re-rated quite significantly.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.